HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Richard J. Thurer Jeffrey P. Jacobs Fred W. Holland, II Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thurer, R. J. Articles by Cintron, J. R. Search for Related Content PubMed PubMed Citation Articles by Thurer, R. J. Articles by Cintron, J. R.

Ann Thorac Surg 1995;60:599-602
© 1995 The Society of Thoracic Surgeons

---

Original Articles: General Thoracic

Surgical Treatment of Lung Cancer in Patients With Human Immunodeficiency Virus

Division of Cardiothoracic Surgery, University of Miami/Jackson Memorial Medical Center, and the Veterans Administration Medical Center, Miami, Florida

Background. Since January 1986, more than 20 patients have been seen at the University of Miami/Jackson Memorial Medical Center and the Miami Veterans Administration Medical Center with concurrent human immunodeficiency virus infection and bronchogenic carcinoma. Four of these patients were treated surgically with curative intent.

Methods. The histories, records, operative reports, and pathology reports of the 4 patients were reviewed.

Results. The 4 surgically treated patients had stage I T1 N0 M0 lung cancer. Three patients had T4 cell counts of less than 200/µL and were managed by lobectomy. These patients died 5, 3, and 5 months postoperatively. More recently, a fourth patient had a T4 cell count of 963/µL and was treated with wedge resection. He is currently alive 12 months postoperatively.

Conclusions. It is concluded that surgically treated patients with lung cancer, human immunodeficiency virus infection, and T4 cell counts lower than 200/µL have high mortality and morbidity. Although it may be best to base surgical intervention on the stage of the patient's human immunodeficiency virus infection, further analysis is essential to determine which subgroup of human immunodeficiency virus–positive patients, if any, would benefit from surgical treatment of lung cancer.

This article has been cited by other articles:

				J Cadranel, D Garfield, A Lavole, M Wislez, B Milleron, and C Mayaud Lung cancer in HIV infected patients: facts, questions and challenges. Thorax, November 1, 2006; 61(11): 1000 - 1008. [Abstract] [Full Text] [PDF]